Quarterly Results

AARTI DRUGS LTD.

NSE : AARTIDRUGSBSE : 524348ISIN CODE : INE767A01016Industry : Pharmaceuticals & DrugsHouse : Aarti
BSE365.005.8 (+1.61 %)
PREV CLOSE ( ) 359.20
OPEN PRICE ( ) 363.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 36136
TODAY'S LOW / HIGH ( )359.75 365.90
52 WK LOW / HIGH ( )312.5 634.9
NSE364.605.2 (+1.45 %)
PREV CLOSE( ) 359.40
OPEN PRICE ( ) 361.40
BID PRICE (QTY) 364.60 (10)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 156000
TODAY'S LOW / HIGH( ) 358.60 365.95
52 WK LOW / HIGH ( )312 635
Quarters
Select year  
( in Million)
Particulars
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Audited / UnAudited
UnAudited
Audited
UnAudited
UnAudited
Net Sales
5566
5983.3
5553.4
6199.9
Total Expenditure
4948.7
5312.8
4903.8
5341.8
PBIDT (Excl OI)
617.3
670.5
649.59
858.09
Other Income
119
14.8
11.1
10.8
Operating Profit
736.29
685.3
660.7
868.9
Interest
90.7
89.3
87.1
91.3
Exceptional Items
NA
NA
NA
NA
PBDT
645.59
596
573.6
777.6
Depreciation
138
137.2
133.8
135.8
Profit Before Tax
507.59
458.8
439.8
641.8
Tax
136.7
109.2
107.1
168.7
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
370.89
349.6
332.7
473.1
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
370.89
349.6
332.7
473.1
Minority Interest
-0.47
0.46
-0.3
0.6
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
370.43
350.06
332.4
473.7
Equity Capital
912.7
912.7
919.4
919.4
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
4.05
3.83
3.61
5.15
Calculated EPS (Annualised)
16.23
15.34
14.46
20.60
No of Public Share Holdings
40723020
40484517
40753147
39411925
% of Public Share Holdings
44.62
44.36
44.33
42.87
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
11.09
11.20
11.69
13.84
PBIDTM%
13.22
11.45
11.89
14.01
PBDTM%
11.59
9.96
10.32
12.54
PBTM%
9.11
7.66
7.91
10.35
PATM%
6.66
5.84
5.99
7.63
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.